Evidence born from ASCOT trial – still important after 15 years

Evidence born from ASCOT trial – still important after 15 years

The paper presents the overview evolution of hypertension identification and treatment during last 15 years after publication of ASCOT trial (AngloScandinavian Cardiac Outcomes Trial) results. It discusses possible mechanism of more significant cardiovascular risk reduction in amlodipine/ perindopri...

Full description

Bibliographic Details
Main Author: O. P. Rotar
Format: Article
Language:Russian
Published: InterMedservice 2021-09-01
Series:Евразийский Кардиологический Журнал
Subjects:
артериальное давление
артериальная гипертензия
комбинированная антигипертензивная терапия
амлодипин
периндоприл
Online Access:https://www.heartj.asia/jour/article/view/6282

Internet

https://www.heartj.asia/jour/article/view/6282

Similar Items